Formulation

Pharma manufacturers are not embracing patient-centric design when it comes to formulation. We need to go beyond tablets and capsules.

Sitting Down With… Robert S. Langer, David H. Koch Institute Professor, Massachusetts Institute of Technology, US.

Forty years ago, it was theorized that chirality had a color composition that could be measured… and finally the theory has been proven.

Meet the analytical experts working at the cutting-edge of pharma analytics to ensure the safety of medicines.

A key focus of Andrew McLachlan’s career is understanding the impact of aging on drug disposition and response to medicines.

The Medicine Maker speaks with Dr. Martin Klatt, Director Sales Pharma Solutions Europe from BASF

The color of a capsule or tablet can have a big impact on compliance and branding. To avoid delays, early decisions have to be made.

The Medicine Maker speaks with Jeanne Thoma, President and CEO from SPI Pharma

In 2018, the UK’s government appointed its first Minister for Loneliness. The role: to tackle loneliness.

With so much technology at our disposal, it’s time to get smart in formulation by adopting in silico approaches.